S&P 500

5.930,85

1,09%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Alpha Tau Medical Ltd (DRTS)
Alpha Tau Medical Ltd (DRTS) Notícias

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:DRTS

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
18/12/2024	10:30	GlobeNewswire Inc.	Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day	NASDAQ:DRTS	Alpha Tau Medical Ltd
17/12/2024	11:00	GlobeNewswire Inc.	Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor	NASDAQ:DRTS	Alpha Tau Medical Ltd
11/12/2024	10:30	GlobeNewswire Inc.	Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
06/12/2024	10:30	GlobeNewswire Inc.	Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium	NASDAQ:DRTS	Alpha Tau Medical Ltd
19/11/2024	18:00	GlobeNewswire Inc.	Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:DRTS	Alpha Tau Medical Ltd
13/11/2024	10:30	GlobeNewswire Inc.	Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
21/10/2024	09:30	GlobeNewswire Inc.	Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme	NASDAQ:DRTS	Alpha Tau Medical Ltd
10/10/2024	09:30	GlobeNewswire Inc.	Alpha Tau Treats First Patient with Recurrent Lung Cancer	NASDAQ:DRTS	Alpha Tau Medical Ltd
20/09/2024	09:30	GlobeNewswire Inc.	Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC	NASDAQ:DRTS	Alpha Tau Medical Ltd
22/08/2024	09:32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:DRTS	Alpha Tau Medical Ltd
22/08/2024	09:30	GlobeNewswire Inc.	Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Con	NASDAQ:DRTS	Alpha Tau Medical Ltd
14/08/2024	17:02	GlobeNewswire Inc.	Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:DRTS	Alpha Tau Medical Ltd
25/06/2024	09:30	GlobeNewswire Inc.	Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers	NASDAQ:DRTS	Alpha Tau Medical Ltd
21/05/2024	09:45	GlobeNewswire Inc.	Alpha Tau to Present at the Jefferies Global Healthcare Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
20/05/2024	17:01	GlobeNewswire Inc.	Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:DRTS	Alpha Tau Medical Ltd
13/05/2024	09:30	GlobeNewswire Inc.	Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer	NASDAQ:DRTS	Alpha Tau Medical Ltd
06/05/2024	09:30	GlobeNewswire Inc.	Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow	NASDAQ:DRTS	Alpha Tau Medical Ltd
01/05/2024	09:30	GlobeNewswire Inc.	Alpha Tau to Participate in May Investor Conferences	NASDAQ:DRTS	Alpha Tau Medical Ltd
25/03/2024	09:50	GlobeNewswire Inc.	Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit	NASDAQ:DRTS	Alpha Tau Medical Ltd
07/03/2024	18:13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DRTS	Alpha Tau Medical Ltd
07/03/2024	18:01	GlobeNewswire Inc.	Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTS	Alpha Tau Medical Ltd
26/02/2024	10:30	GlobeNewswire Inc.	Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
20/12/2023	11:15	GlobeNewswire Inc.	Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
18/12/2023	13:09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DRTS	Alpha Tau Medical Ltd
29/11/2023	10:30	GlobeNewswire Inc.	Alpha Tau to Participate in Sidoti Small-Cap Conference	NASDAQ:DRTS	Alpha Tau Medical Ltd
28/11/2023	10:30	GlobeNewswire Inc.	Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	NASDAQ:DRTS	Alpha Tau Medical Ltd
20/11/2023	10:30	GlobeNewswire Inc.	Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer	NASDAQ:DRTS	Alpha Tau Medical Ltd
16/11/2023	18:30	GlobeNewswire Inc.	Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTS	Alpha Tau Medical Ltd
30/10/2023	09:30	GlobeNewswire Inc.	Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility	NASDAQ:DRTS	Alpha Tau Medical Ltd
24/10/2023	10:00	GlobeNewswire Inc.	Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board	NASDAQ:DRTS	Alpha Tau Medical Ltd